Search Count: 23
![]() |
Crystal Structure Of The Mutant Human Ror Gamma Ligand Binding Domain With Jte-151
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-11-27 Classification: NUCLEAR PROTEIN/INHIBITOR Ligands: YAL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2023-11-29 Classification: IMMUNE SYSTEM Ligands: CL, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2023-11-29 Classification: IMMUNE SYSTEM Ligands: GOL |
![]() |
Structure Of Vhh-Fab Complex With Engineered Elbow Fnqikg, Crystal Kappa And Ser Substitutions
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.52 Å Release Date: 2023-11-29 Classification: IMMUNE SYSTEM Ligands: SIN, PEG, PO4, CL |
![]() |
Structure Of Vhh-Fab Complex With Engineered Elbow Fnqikg And Crystal Kappa Regions
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.52 Å Release Date: 2023-11-29 Classification: IMMUNE SYSTEM Ligands: PEG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.50 Å Release Date: 2023-11-22 Classification: IMMUNE SYSTEM Ligands: EPE, SO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-11-22 Classification: IMMUNE SYSTEM Ligands: EDO, CL, PEG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2023-11-22 Classification: IMMUNE SYSTEM Ligands: EDO, NA, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-11-22 Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Ligands: EDO, PEG, CL, NA |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2023-11-22 Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Ligands: CL, NA |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2023-11-22 Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Ligands: BTB, PEG, EDO, ACT, NA, CL |
![]() |
C-Terminal Bromodomain Of Human Brd2 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: NUB, MES |
![]() |
C-Terminal Bromodomain Of Human Brd2 With (S)-5-(1-((1-Acetylpiperidin-3-Yl)Methyl)-5-Bromo-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: EDO, MES, I0U |
![]() |
N-Terminal Bromodomain Of Human Brd4 With (S)-5-(1-((1-(1-Isopropylpiperidine-4-Carbonyl)Piperidin-3-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: I0Z |
![]() |
Crystal Structure Of The Mutant Human Ror Gamma Ligand Binding Domain With Rockogenin.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2017-06-07 Classification: TRANSFERASE/IHIBITOR Ligands: 82R |
![]() |
Crystal Structure Of The Mutant Human Ror Gamma Ligand Binding Domain With Ursolic Acid.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2017-06-07 Classification: TRANSFERASE/INHIBITOR Ligands: 6Q5 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-06-07 Classification: TRANSFERASE/INHIBITOR |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-06-07 Classification: TRANSCRIPTION/INHIBITOR |
![]() |
Crystal Structure Of The Mutant Human Ror Gamma Ligand Binding Domain With Compound A.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2017-06-07 Classification: TRANSFERASE/INHIBITOR Ligands: 82O |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-03-02 Classification: DNA BINDING PROTEIN/INHIBITOR Ligands: 4LQ |




















